1. Home
  2. BPYPO vs GRMLW Comparison

BPYPO vs GRMLW Comparison

Compare BPYPO & GRMLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Property Partners L.P.

BPYPO

Brookfield Property Partners L.P.

HOLD

Current Price

$15.35

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

GRMLW

Greenland Mines Ltd Warrant

N/A

Current Price

$0.26

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BPYPO
GRMLW
Founded
N/A
N/A
Country
Bermuda
United States
Employees
24000
5
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BPYPO
GRMLW
Price
$15.35
$0.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.6K
23.6K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.87
$0.10
52 Week High
$16.26
$0.37

Technical Indicators

Market Signals
Indicator
BPYPO
GRMLW
Relative Strength Index (RSI) 53.72 59.50
Support Level $14.62 $0.13
Resistance Level $15.37 $0.26
Average True Range (ATR) 0.19 0.04
MACD -0.02 0.00
Stochastic Oscillator 55.36 73.91

Price Performance

Historical Comparison
BPYPO
GRMLW

About BPYPO Brookfield Property Partners L.P.

Brookfield Property Partners LP owns and operates in North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.

About GRMLW Greenland Mines Ltd Warrant

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Share on Social Networks: